AMTM Amentum Holdings, Inc. Insider Trading

Director Loughran Barbara purchases 4,600 shares of AMTM at $21.22; stock now -37.9% from 52-week high.

Director Barbara Loughran initiated a position with a $97,635.00 purchase of 4,600 shares at $21.22 on 2025-02-18, establishing her first disclosed holding in Amentum. The transaction occurs as the stock trades $20.75, down 12.0% over 30 days and 37.9% below its 52-week high of $33.40. The company posted a $3.4B quarterly revenue and 6.6% annual growth, but reported negative full-year net income, despite recording $12.0M net income in the latest quarter. The timing of a director's initial acquisition against deteriorating recent price momentum and the company's return to profitability raises questions about conviction signals versus reversal expectations in a volatile period.

AMTM Executive Chair Steven Demetriou buys 100,000 shares at $20.81; stock down 40.7% from 52-week high.

Demetriou purchased 100,000 shares (100.0K shares) at $20.81 on 2025-02-12, increasing his holdings to 620,893 shares (620.9K shares), a 19.2% increase in his stake. This open-market purchase by the Executive Chair occurs against a backdrop of significant stock weakness: the stock is trading at $19.80, down 40.7% from its 52-week high of $33.40 and down 15.6% over the prior 30 days. The company reported latest quarter revenue of $3,416,000,000.00 ($3.4B) with net income of $12,000,000.00 ($12.0M), though notably the company was unprofitable over its most recent full fiscal year. Demetriou's prior open-market buy showed a 90-day return of +23.1%, but his cross-ticker track record on prior sells achieved a 75.00% well-timed rate with a -4.3% average 90-day return, indicating historical execution discipline. The timing of this substantial purchase during a period of depressed valuation and negative momentum warrants attention to whether management views current prices as a dislocation opportunity.